Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Variceal hemorrhage is one of the major complications of cirrhosis and is associated with significant mortality and morbidity. The development of gastroesophageal varices and variceal hemorrhage is the most direct consequence of portal hypertension. Correlations between the hepatic venous pressure gradient (HVPG) and first variceal hemorrhage were examined. Methods: Patients with cirrhosis who underwent HVPG measurement between July 2009 and September 2010 were enrolled (n=535). All patients underwent esophagogastroduodenoscopy to enable the evaluation of gastroesophageal varices. Results: The HVPG for all patients was 16.46±7.05 mmHg (mean±SD), and was significantly higher among those with first variceal hemorrhage than in those without it. The HVPG was significantly correlated with both Child-Turcotte-Pugh (r=0.488, P<0.001) and Model for End-stage Liver Disease (r=0.478, P<0.001) scores. An HVPG value of 11 mmHg was predictive of first variceal hemorrhage with a sensitivity of 92.4% and a specificity of 27.7%. Conclusions: The HVPG was higher in patients with first variceal hemorrhage than in those without it. (Clin Mol Hepatol 2012;18:391-396)
Abstract
Background/Aims: Variceal hemorrhage is one of the major complications of cirrhosis and is associated with significant mortality and morbidity. The development of gastroesophageal varices and variceal hemorrhage is the most direct consequence of portal hypertension. Correlations between the hepatic venous pressure gradient (HVPG) and first variceal hemorrhage were examined. Methods: Patients with cirrhosis who underwent HVPG measurement between July 2009 and September 2010 were enrolled (n=535). All patients underwent esophagogastroduodenoscopy to enable the evaluation of gastroesophageal varices. Results: The HVPG for all patients was 16.46±7.05 mmHg (mean±SD), and was significantly higher among those with first variceal hemorrhage than in those without it. The HVPG was significantly correlated with both Child-Turcotte-Pugh (r=0.488, P<0.001) and Model for End-stage Liver Disease (r=0.478, P<0.001) scores. An HVPG value of 11 mmHg was predictive of first variceal hemorrhage with a sensitivity of 92.4% and a specificity of 27.7%. Conclusions: The HVPG was higher in patients with first variceal hemorrhage than in those without it. (Clin Mol Hepatol 2012;18:391-396)
참고문헌 (19)
- 백순구, "문맥압 항진증을 동반한 간경변 환자에서 propranolol이 문맥압에 미치는 효과", 대한내과학회지, 64(6), pp.639~646 (2003), 대한내과학회
- 김문영, "간경변증 환자에서 간정맥 압력차와 간경변증의 임상병기, 정맥류및 복수와의 상관관계", Clinical and Molecular Hepatology, 14(2), pp.150~158 (2008), 대한간학회
- Paik YH, "The relation between hepatic venous pressure gradient and complications of liver cirrhosis", Korean J Hepatol, 14, pp.136~138 (2008)
- Wadhawan M, "Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child’s status", Dig Dis Sci, 51, pp.2264~2269 (2006)
- 김문영, "문맥압항진증의 병태생리 및 진단", 대한내과학회지, 75(1), pp.1~5 (2008), 대한내과학회
- Ripoll C, "Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era", Hepatology, 42, pp.793~801 (2005)
- Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis", N Engl J Med, 353, pp.2254~2261 (2005)
- Garcia-Tsao G, "Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference", Hepatology, 47, pp.1764~1772 (2008)
- Groszmann RJ, "The hepatic venous pressure gradient: anything worth doing should be done right", Hepatology, 39, pp.280~282 (2004)
- 이성화, "비대상성 간경변증 환자의 예후지표로서 Model for End-stage Liver Disease와 간정맥압차의 비교", Clinical and Molecular Hepatology, 15(3), pp.350~356 (2009), 대한간학회
- 백순구, "Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response", RADIOLOGY, 240(2), pp.574~580 (2006)
- Lebrec D, "Methods to evaluate portal hypertension", Gastroenterol Clin North Am, 21, pp.41~59 (1992)
- Tajiri T, "General rules for recording endoscopic findings of esophagogastric varices (2nd edition)", Dig Endosc, 22, pp.1~9 (2010)
- de Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 53, pp.762~768 (2010)
- Kamath PS, "A model to predict survival in patients with endstage liver disease", Hepatology, 33, pp.464~470 (2001)
- Baik SK, "Assessment and current treatment of portal hypertension", Korean J Hepatol, 11, pp.211~217 (2005)
- Albillos A, "Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis", Am J Gastroenterol, 102, pp.1116~1126 (2007)
- Huo TI, "Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis", Liver Int, 27, pp.498~506 (2007)
- Wang YW, "Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis", J Clin Gastroenterol, 41, pp.706~712 (2007)